Inhibiting Pyk2/Src expression by miR-23b-3p suppressed liver cancer stem cell function and hepatic carcinoma progression
Abstract Background Liver cancer stem cells (LCSCs) are critical drivers of metastasis and chemoresistance in hepatocellular carcinoma (HCC). Proline-rich tyrosine kinase 2 (Pyk2) has been implicated in tumor progression, but its role in LCSC stemness and HCC malignancy remains unclear. This study e...
Saved in:
| Main Authors: | Meng Sha, Jiang Zhang, Jin-kai Liu, Xiao-ye Qu, Chuan Shen, Ying Tong, Jie Cao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12935-025-03841-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment of in vitro Src tyrosine kinase inhibitors screening model
by: WANG Chen-hui, et al.
Published: (2007-11-01) -
Recent advances of miR-23 in human diseases and growth development
by: Xu Qian, et al.
Published: (2025-04-01) -
miR-23b is a negative regulator of tumor suppressing PTPRG in colorectal cancer
by: Hong Duan, et al.
Published: (2025-09-01) -
Serum levels of miR-21, miR-23a, miR-142-5p, and miR-126 in chronic failure with reduced ejection fraction: a case-control study
by: Lukas Evin, et al.
Published: (2025-05-01) -
p65/miR‐23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma
by: Zhi‐Qin Li, et al.
Published: (2020-01-01)